Ashley Kay Wiginton, PA

Ashley Wiginton practices at Healthtexas Provider Network in Dallas, Texas.

Ashley Wiginton's NPI, 1326310665, was assigned on February 2, 2012. Ashley Wiginton holds Texas license PA07651.

Ashley Wiginton's primary practice is Healthtexas Provider Network, at 301 N Washington Ave, Dallas, TX 75246 in Dallas County. The practice phone is (214) 820-3466.

Ashley Wiginton's primary practice is Healthtexas Provider Network in Dallas, Texas. The medical group on file is HealthTexas Provider Network (HTPN). Dmand AI also links Ashley Wiginton to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ashley Wiginton practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Ashley Wiginton's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Ashley Wiginton is licensed in Texas.

CMS data shows 329 Medicare services from Ashley Wiginton across 5 procedure codes in 2024, for 116 Medicare patients. Medicare paid $12,695 for them. Every service was in an office.

CMS counts 116 Medicare patients who saw Ashley Wiginton in 2024. The largest group is 65 to 74, with 69 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ashley Wiginton's median patient age at 65, with 51% women.

In 2024, Ashley Wiginton wrote 516 Medicare Part D claims for 122 patients. 76% of them were for generic drugs. CMS names the drug for 420 of them, across 16 drugs with 11 or more claims each, at $1,059,426 in total drug cost.

Ashley Wiginton accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Ashley Wiginton as offering telehealth.

CMS Open Payments shows 81 general payments to Ashley Wiginton from 9 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $505.